To then determine if these inflammasome signaling proteins have the potential to be reliable biomarkers for MS pathology, we determined the area under the curve (AUC) for caspase-1 (Figure 2A), ASC (Figure 2B), IL-1β (Figure 2C), and IL-18 (Figure 2D). The gene discussed is IL18; the disease is myeloid sarcoma.